4-((S)-2-((S)-2-((tert-butoxycarbonyl)amino)-3-phenylpropanamido)-3-oxo-3-(pent-4-yn-1-ylamino)propyl)phenyl ethenesulfonate

Catalog No. :
ACRIAG620
CAS No. :
1461648-55-4
Molecular Formula :
C30H37N3O7S
Molecular Weight :
583.71

IUPAC Name:4-((S)-2-((S)-2-((tert-butoxycarbonyl)amino)-3-phenylpropanamido)-3-oxo-3-(pent-4-yn-1-ylamino)propyl)phenyl ethenesulfonate

4-((S)-2-((S)-2-((tert-butoxycarbonyl)amino)-3-phenylpropanamido)-3-oxo-3-(pent-4-yn-1-ylamino)propyl)phenyl ethenesulfonate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((S)-2-((S)-2-((tert-butoxycarbonyl)amino)-3-phenylpropanamido)-3-oxo-3-(pent-4-yn-1-ylamino)propyl)phenyl ethenesulfonate
IUPAC Name4-((S)-2-((S)-2-((tert-butoxycarbonyl)amino)-3-phenylpropanamido)-3-oxo-3-(pent-4-yn-1-ylamino)propyl)phenyl ethenesulfonate
Molecular FormulaC30H37N3O7S
Molecular Weight583.71
SMILESC#CCCCNC(=O)[C@H](CC1=CC=C(OS(=O)(=O)C=C)C=C1)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)OC(C)(C)C
InChI KeyRNMDSOKRNOMQFX-UIOOFZCWSA-N
SynonymN-[(1,1-Dimethylethoxy)carbonyl]-L-phenylalanyl-O-(ethenylsulfonyl)-N-4-pentyn-1-yl-L-tyrosinamide
CAS No.1461648-55-4
PubChem CID91826082

Synthetic Route by SureRoute

1. ACRIAG620 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRIAG620 route product structure diagram
    ACRIAG6201461648-55-4
Inquiry

2. ACRIAG620 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLJTG081 route compound structure diagram
    ACLJTG0816608-47-5 In Stock
  4. Then
  5. ACRIAG620 route product structure diagram
    ACRIAG6201461648-55-4
Inquiry

Comments (0)